重组PE Anti-Cdk6抗体[EPR4515]
PE Anti-Cdk6 antibody [EPR4515]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CDK6 antibody - conjugated to PE.
查看别名
CDKN6, CDK6, Cyclin-dependent kinase 6, Cell division protein kinase 6, Serine/threonine-protein kinase PLSTIRE
不同偶联物与剂型 (10)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cdk6 antibody [EPR4515]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cdk6 antibody [EPR4515]
-
660 APC
APC Anti-Cdk6 antibody [EPR4515]
-
HRP Anti-Cdk6 antibody [EPR4515]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cdk6 antibody [EPR4515]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cdk6 antibody [EPR4515]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Cdk6 antibody [EPR4515]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Cdk6 antibody [EPR4515]
-
Anti-Cdk6 antibody [EPR4515]
-
Anti-Cdk6 antibody [EPR4515] - BSA and Azide free
产品详情
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdk6 functions as a regulator of the cell cycle. It participates in a complex with cyclin D to control the G1 phase progression. This activity is essential for the regulation of cell division and proliferation. The association with cyclin D allows Cdk6 to phosphorylate the retinoblastoma protein (Rb) leading to the release of E2F transcription factors that promote the expression of genes necessary for DNA synthesis.
Pathways
Cdk6 is an important component of the cell cycle control pathway. It interacts primarily with the retinoblastoma protein and Cyclin D1 in this context. The cell cycle pathway is critical for controlled cell proliferation and its dysregulation can lead to diseases like cancer. Another involved pathway is the PI3K/AKT pathway which can activate Cdk6 activity through upstream signaling events implicating Cdk6 in cellular responses to growth signals.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com